लोड हो रहा है...
Estrogen Inhibition Reverses Pulmonary Arterial Hypertension and Associated Metabolic Defects
Increased estrogen is a strong epidemiologic risk factor for development of pulmonary arterial hypertension (PAH) in patients, associated with metabolic defects. Estrogens also drive penetrance in mice carrying mutations in BMPR2, the cause of most heritable PAH. The goal of the present study was to...
में बचाया:
| में प्रकाशित: | Eur Respir J |
|---|---|
| मुख्य लेखकों: | , , , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2017
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6532788/ https://ncbi.nlm.nih.gov/pubmed/28775043 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.02337-2016 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|